2-苄基哌啶
外觀
臨床資料 | |
---|---|
給藥途徑 | 口服 |
ATC碼 |
|
法律規範狀態 | |
法律規範 |
|
識別資訊 | |
| |
CAS號 | 32838-55-4 |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.046.581 |
化學資訊 | |
化學式 | C12H17N |
摩爾質量 | 175.28 g·mol−1 |
3D模型(JSmol) | |
| |
|
2-苄基哌啶(英語:2-Benzylpiperidine)是哌啶類的興奮劑藥物。它在結構上與哌甲酯和2-二苯甲基哌啶等其他藥物相似,但效力大約是其二十分之一。雖然它能將去甲腎上腺素水平提高到與右旋苯丙胺大致相同的程度,[1]但它對多巴胺水平的影響非常小,其對多巴胺轉運蛋白的結合親和力比去甲腎上腺素轉運蛋白低約175倍。[2]2-苄基哌啶很少用作興奮劑,它主要用作製造其他藥物的合成中間體。[3][4][5]
參見
[編輯]參考資料
[編輯]- ^ Ferris RM, Tang FL. Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-[3H]norepinephrine and [3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus. The Journal of Pharmacology and Experimental Therapeutics. September 1979, 210 (3): 422–8. PMID 39160.
- ^ Kim DI, Deutsch HM, Ye X, Schweri MM. Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate. Journal of Medicinal Chemistry. May 2007, 50 (11): 2718–31. PMID 17489581. doi:10.1021/jm061354p.
- ^ Ablordeppey SY, Fischer JB, Law H, Glennon RA. Probing the proposed phenyl-A region of the sigma-1 receptor. Bioorganic & Medicinal Chemistry. August 2002, 10 (8): 2759–65. PMID 12057665. doi:10.1016/S0968-0896(02)00096-2.
- ^ Ágai B, Proszenyák A, Tárkányi G, Vida L, Faigl F. Convenient, Benign and Scalable Synthesis of 2- and 4-Substituted Benzylpiperidines.. European Journal of Organic Chemistry. 2004, 2004 (17): 3623–3632. doi:10.1002/ejoc.200400215.
- ^ US 6124317,Bigge CF, Keana JR, Cai SX, Weber E, Woodward R, Lan NC, Guzikowski AP,「2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists.」